Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials

Annals of Oncology

Volumn 23, Issue 9, 2012, Pages 2464-2469

  Stiller, C A ^a   Kroll, M E ^a,b   Pritchard jones, K ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer registry; Childhood cancer; Clinical trials; Population based; Survival; Trends

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; EWING SARCOMA; FEMALE; GERM CELL TUMOR; GONADAL CELL TUMOR; HEPATOBLASTOMA; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY; UNITED KINGDOM;

EID: 84865556978     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds183     Document Type: Article

References (45)

1. Stiller C. Childhood cancer in Britain: incidence, survival, mortality. Oxford: Oxford University Press 2007.
2. Medical Research Council's Working Party on Leukaemia in Childhood. Treatment of acute lymphoblastic leukaemia Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen (Concord Trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood. Br Med J 1971; 4(5781): 189-194.
3. Medical Research Council's Working Party on Leukaemia in Childhood. Treatment of acute lymphoblastic leukaemia: effect of variation in length of treatment on duration of remission. Report to the Medical Research Council by the Working Party on Leukaemia in Childhood. Br Med J 1977; 2(6085): 495-497.
4. Medical Research Council's Working Party on Leukaemia in Adults. Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine, L-asparaginase, prednisone and thioguanine: results of treatment with five multiple-drug schedules. Br J Haematol 1974; 27(3): 373-389.
5. Makepeace AR, MacLennan KA, Vaughan Hudson G et al. Hodgkin's disease in childhood: the British National Lymphoma Investigation Experience (BNLI Report No 27). Clin Radiol 1987; 38(1): 7-11.
6. Medical Research Council's Working Party on Embryonal Tumours in Childhood. Management of nephroblastoma in childhood. Clinical study of two forms of maintenance chemotherapy. Arch Dis Child 1978; 53(2): 112-119.
7. Mott MG, Mann JR, Stiller CA. The United Kingdom Children's Cancer Study Group - the first 20 years of growth and development. Eur J Cancer 1997; 33 (9): 1448-1452.
8. Mott MG, Eden OB, Palmer MK. Adjuvant low dose radiation in childhood non-Hodgkin's lymphoma. (Report from the United Kingdom Children's Cancer Study Group - UKCCSG). Br J Cancer 1984; 50(4): 463-469.
9. Mott MG, Chessells JM, Willoughby MLN et al. Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma. (Report from the United Kingdom Children's Cancer Study Group - UKCCSG). Br J Cancer 1984; 50(4): 457-462.
10. Stiller CA, Draper GJ. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child 1989; 64(5): 657-661.
11. Stiller CA, Eatock EM. Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study. Arch Dis Child 1994; 70(3): 219-223.
12. Stiller CA, Eatock EM. Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980-94. Arch Dis Child 1999; 81 (3): 202-208.
13. Stiller CA, Passmore SJ, Kroll ME et al. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994. Br J Cancer 2006; 94(1): 22-29.
14. Stiller CA, Pritchard J, Steliarova-Foucher E. Liver cancer in European children: incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42(13): 2115-2123.
15. Stiller CA, Bielack SS, Jundt G et al. Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42(13): 2124-2135.
16. Pastore G, Viscomi S, Gerov GL et al. Population-based survival after childhood lymphoblastic leukaemia in time periods corresponding to specific clinical trials from 1979-1998 - a report from the Childhood Cancer Registry of Piedmont (Italy). Eur J Cancer 2003; 39(7): 952-960.
17. Steliarova-Foucher E, Stiller C, Lacour B et al. International Classification of Childhood Cancer, third edition. Cancer 2005; 103(7): 1457-1467.
18. Tait DM, Thornton-Jones H, Bloom HJG et al. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990; 26(4): 464-469.
19. Maurer HM, Gehan EA, Beltangady M et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993; 71(5): 1904-1922.
20. Crist W, Gehan EA, Ragab AH et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995; 13(3): 610-630.
21. Eden OB, Lilleyman JS, Richards S et al. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br J Haematol 1991; 78(2): 187-196.
22. Mitchell CD, Richards SM, Kinsey SE et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol 2005; 129(6): 734-745.
23. Mitchell C, Payne J, Wade R et al. The impact of risk stratification by early bonemarrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99. Br J Haematol 2009; 146(4): 424-436.
24. Craft AW, Cotterill SJ, Bullimore JA et al. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). Eur J Cancer 1997; 33(7): 1061-1069.
25. Mann JR, Pearson D, Barrett A et al. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer 1989; 63(9): 1657-1667.
26. Pearson ADJ, Pinkerton CR, Lewis IJ et al. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. Lancet Oncol 2008; 9(3): 247-256.
27. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35(1): 1-39.
28. Cox DR. Regression models and life tables. J R Stat Soc Ser B 1972; 34(2): 187-220.
29. Stata Statistical Software: Release 9. College Station, TX: StataCorp LP 2005.
30. McNeil DE, Coté TR, Clegg L et al. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Med Pediatr Oncol 2002; 39(3): 190-194.
31. Packer RJ, Biegel JA, Blaney S et al. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 2002; 24 (5): 337-342.
32. Chessells JM, Harrison G, Richards SM et al. Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI. Br J Haematol 2002; 118(2): 445-455.
33. Lawson SE, Harrison G, Richards S et al. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. Br J Haematol 2000; 108(3): 531-543.
34. Chessells JM, Harrison CJ, Watson SL et al. Treatment of infants with lymphoblastic leukaemia: results of the UK infant protocols 1987-1999. Br J Haematol 2002; 117(2): 306-314.
35. Pieters R, Schrappe M, De Lorenzo P et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007; 370(9583): 240-250.
36. Gibson BES, Wheatley K, Hann IM et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005; 19 (12): 2130-2138.
37. Pritchard J, Brown J, Shafford E et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach - results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 2000; 18(22): 3819-3828.
38. Chessells JM, Eden OB, Bailey CC et al. Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials Report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia 1994; 8(8): 1275-1279.
39. Bramwell VHC, Burgers M, Sneath R et al. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992; 10(10): 1579-1591.
40. Souhami RL, Craft AW, van der Eijken JW et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997; 350(9082): 911-917.
41. Lewis IJ, Nooij MA, Whelan J et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007; 99(2): 112-128.
42. Craft A, Cotterill S, Malcolm A et al. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The second United Kingdom children's cancer study group and the medical research council Ewing's tumor study. J Clin Oncol 1998; 16(11): 3628-3633.
43. Paulussen M, Craft AW, Lewis I et al. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment-cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 2008; 26(27): 4385-4393.
44. Groot-Loonen JJ, Pinkerton CR, Morris-Jones PH et al., On behalf of the United Kingdom Children's Cancer Study Group. How curable is relapsed Wilms' tumour? Arch Dis Child 1990; 65(9): 968-970.
45. Feuer EJ, Kessler LG, Baker SG et al. The impact of breakthrough clinical trials on survival in population based tumor registries. J Clin Epidemiol 1991; 44(2): 141-153.